Note the disclosure, bottom of Temple page: "Editor's note: Neither Dr. George nor Dr. Houser has any financial interest in Baxter Healthcare Corporation." He doesn't give a BAXTER disclosure because the trial is for BHRT??
It's pretty cut n dry. Has ZIP to do with BHRT and is not even the same technology- it's bone marrow derived cells. All explained in the links above. And no- the researcher is not under some "mystery" name- he's listed all over these PR's and it's FOR BAXTER and THEIR TRIAL.
It's not Bioheart, like hop says since it is bone marrow derived. However, Bioheart probably tweeted it to show the immense interest there is today with stem cells for heart repair. Bioheart tends to not knock competition I have noticed. They believe in a friendly competition to get to market.